Older patients can skip breast radiation - study

Key points
- Older women with early stage breast cancer can safely skip radiation therapy and go straight to taking pills that help keep tumors from coming back, researchers reported on Thursday.
- They said the finding, to be presented next month to a meeting of the American Society of Clinical Oncology, may save many women and their doctors a lot of trouble, not to mention the costs of radiation.
- "This study confirms that for older women with early stage breast cancer, lumpectomy without radiation is a viable alternative, and tamoxifen may replace the need for radiation," said Dr.
- Hughes and colleagues now have 12 years of data on 636 women aged 70 or older who had stage I breast cancer, the easy-to-cure type that has not spread and that is so-called estrogen receptor-positive.
Older women with early stage breast cancer can safely skip radiation therapy and go straight to taking pills that help keep tumors from coming back, researchers reported on Thursday.
They said the finding, to be presented next month to a meeting of the American Society of Clinical Oncology, may save many women and their doctors a lot of trouble, not to mention the costs of radiation.
"This study confirms that for older women with early stage breast cancer, lumpectomy without radiation is a viable alternative, and tamoxifen may replace the need for radiation," said Dr. Kevin Hughes of Massachusetts General Hospital in Boston, who led the study.
Hughes and colleagues now have 12 years of data on 636 women aged 70 or older who had stage I breast cancer, the easy-to-cure type that has not spread and that is so-called estrogen receptor-positive.
The women had the tumors removed in an operation called a lumpectomy. Half got radiation treatment and then took five years of tamoxifen, a pill that has been shown to cut in half the risk that breast cancer will return.
The other half went straight to tamoxifen.
Twelve years later, 12 women who got radiation had died from their breast cancer, compared to eight who got tamoxifen only, Hughes told reporters in a telephone briefing. Many of the women died, but more than 95 percent died from something other than breast cancer.
"We did find that radiation did have some benefits in terms of in-breast recurrences but those benefits are relatively small," Hughes said.
He said 26 women who did not have radiation got new tumors in the same breast, compared to six women who had radiation. Those women could have the new tumors removed and then have radiation later.
ASCO president Dr. Douglas Blayney said the work showed that publicly funded, academic research can help patients in ways that research done by the pharmaceutical industry and device makers would not. "This is the kind of study that would not be done ... if we relied on industry," Blayney said.
"I think that many women and their physicians currently don't do radiation. This gives us comfort in the fact that this is a reasonable course of action," Blayney said.
(Editing by Vicki Allen)
--
* Radiation did not add extra protection
* Most women died of something else
By Maggie Fox, Health and Science Editor
WASHINGTON, May 20 (Reuters)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsSome older cancer patients can avoid radiotherapy, study finds
Some older women with breast cancer could safely avoid radiotherapy, without harming their chances of survival, a study has shown. Older women with early breast cancer who are given breast-conserving surgery and hormone…
29 January 2015
NewsHerceptin found to improve long-term survival of HER2-positive breast cancer patients
VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute (NCI)-supported clinical…
16 December 2014
NewsTherapy Found Effective in Older, African American Lung Cancer Patients
University of Cincinnati researchers have found in a phase-2 clinical trial that a Food and Drug Administration-approved therapy could be effective in treating both older and African American patients with advanced lung…



